Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
First Wave Bio (FWBI)
NASDAQ:FWBI
First Wave Bio (FWBI) Stock Price & Analysis
1,167 Followers
FWBI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.27 - $16.38
Previous Close$0.29
Volume510.73K
Average Volume (3M)3.69M
Market Cap
$3.90M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.24M
Total Debt (Recent Filing)$401.70K
Price to Earnings (P/E)<0.1
Beta1.26
Next Earnings
Aug 13, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)10.52
Shares Outstanding7,152,204
10 Day Avg. Volume1,281,329
30 Day Avg. Volume3,689,182
Standard Deviation0.26
R-Squared0.11
Alpha-0.13
Financial Highlights & Ratios
Price to Book (P/B)-2.67
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
First Wave Bio News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
FWBI FAQ
What was First Wave Bio’s price range in the past 12 months?
First Wave Bio lowest stock price was $0.27 and its highest was $16.38 in the past 12 months.
What is First Wave Bio’s market cap?
Currently, no data Available
When is First Wave Bio’s upcoming earnings report date?
First Wave Bio’s upcoming earnings report date is Aug 13, 2019 which is 1509 days ago.
How were First Wave Bio’s earnings last quarter?
Currently, no data Available
Is First Wave Bio overvalued?
According to Wall Street analysts First Wave Bio’s price is currently Overvalued.
Does First Wave Bio pay dividends?
First Wave Bio does not currently pay dividends.
What is First Wave Bio’s EPS estimate?
First Wave Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does First Wave Bio have?
First Wave Bio has 13,463,479 shares outstanding.
What happened to First Wave Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of First Wave Bio?
Currently, no hedge funds are holding shares in FWBI
---
First Wave Bio Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Insider Transactions
Sold Shares
Worth $10.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.2%
Last 30 Days ▲ 11.3%
Last 30 Days ▲ 11.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-97.14%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
10.20%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
First Wave Bio
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It focuses on MS1819-SD, and B-Lactamase program products. The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY.
---
Top 5 ETFs holding FWBI
iShares Core S&P Total U.S. Stock Market ETF
$109.04
Up to five ETFs with an Outperform Smart Score that hold FWBI. The ETFs are listed according to market value of FWBI within the ETF
---